PrescriberPoint Raises Significant Growth Investment from Lilly, Pfizer, Adobe, and Mastercard with a Mission to Reimagine the Traditional HCP-Pharmaceutical Company Engagement Model

PrescriberPoint, a digital marketplace where Healthcare Providers (“HCPs”) can find all of the resources and support they need in one place to get their patients on therapy, for any FDA or OTC-approved medication, announced its Series Seed investment today. Eli Lilly and Company, Pfizer Inc., Adobe Inc., and Mastercard Incorporated participated in the round. PrescriberPoint is creating a digital ecosystem based on a “pull” (vs. “push”) model where HCPs can access all the support they need from life science, insurance and pharmacy companies industry-wide, on their terms, in one place. Providers have access to product information, coverage and affordability details, and support to help streamline their prescribing workflow and save their practice valuable time. Dan Cornwell, CEO at PrescriberPoint, said: “We are on a mission to get patients on therapy more efficiently by connecting HCPs with the right resources at the right time. We believe an industry-wide, aggregation approach is what HCPs need to deal with the incredibly fragmented and frustrating challenge today of working with so many pharmaceutical, insurance, and pharmacy companies to navigate coverage details and affordability options for their patients. “We see what we’re doing as similar to what other innovative companies did in equally fragmented industries such as travel, real estate, automotive and financial services where ‘one-stop’ became the b...
Source: EMR and HIPAA - Category: Information Technology Authors: Tags: Health IT Company Healthcare IT Adobe Adobe Inc. Dan Cornwell Digital Ecosystem Diogo Rau Eli Lilly Eli Lilly and Company FDA Hannah Elsakr HCP HCPs Health IT Funding Health IT Fundings Health IT Investment healthcare provi Source Type: blogs